Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,905 total articles

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

Capricor Therapeutics announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) target action date for its Biologics License Application (BLA) for Deramiocel, a novel cell therapy for Duchenne muscular dystrophy (DMD), from August 22, 2026 to November 22, 2026. The extension follows submission of new 24-month open-label extensi…

Cyabra Secures Contracts with Two European National Security Government Agencies, with Total Annual Revenues of more than $500,000

Cyabra Secures Contracts with Two European National Security Government Agencies, with Total Annual Revenues of more than $500,000

Cyabra, Inc., a Nasdaq-listed AI-powered narrative intelligence company, announced contracts with two European national security government agencies valued at over $500,000 annually. These agreements will deploy Cyabra's AI platform to detect and mitigate foreign information manipulation, coordinated bot networks, and AI-amplified narrative threats…

Dave & Buster's Strengthens Executive Leadership Team to Support Growth, Operational Excellence and Innovation

Dave & Buster's Strengthens Executive Leadership Team to Support Growth, Operational Excellence and Innovation

Dave & Buster's Entertainment, Inc. announces key executive hires and promotions including a new COO, CMO, CTO, Chief Legal Officer, and other leadership roles to support its strategic priorities for growth, operational efficiency, and innovation. These leadership enhancements align with the company’s focus on driving same store sales, EBITDA growt…

GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026

GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026

GRI Bio, a US-based biotech firm specializing in inflammatory and fibrotic diseases, will present compelling Phase 2a data from its oral RAR β/γ-selective agonist, GRI-0621, at the 2026 European Respiratory Society Congress. The data demonstrate favorable lung function improvement, anti-fibrotic biomarker activity, and good tolerability in idiopath…

Tyson Foods, Inc. Announces Early Tender Results

Tyson Foods, Inc. Announces Early Tender Results

Tyson Foods, Inc. announced the early results of its tender offers to purchase several series of its senior notes due in 2027 and 2029. The company reported valid tenders exceeding the maximum purchase cap and plans to accept a portion on a pro rata basis. Tyson Foods has also amended the offers by eliminating the 5.400% 2029 tender sub-cap, mainta…

VIVAKOR'S TRADING PLATFORM SURPASSES $2 BILLION MILESTONE

VIVAKOR'S TRADING PLATFORM SURPASSES $2 BILLION MILESTONE

Vivakor, Inc., a Nasdaq-listed integrated energy company, announced that its subsidiary Vivakor Supply & Trading (VST) has exceeded $2.35 billion in annualized commercial activity through crude oil sales. Due to rapid expansion and new commercial opportunities, the company has raised its 2026 outlook for annualized commercial activity to $3.5 billi…

Beyond Immerse™ Now Available at Erewhon

Beyond Immerse™ Now Available at Erewhon

Beyond Meat announced the availability of its new functional beverage line, Beyond Immerse, at Erewhon locations across Southern California. This follows previous rollouts in New York and direct-to-consumer channels. Beyond Immerse offers plant-based protein, fiber, antioxidants, and electrolytes in a lightly sparkling drink, expanding Beyond Meat'…

/CORRECTION - Ming Shing Group Holdings Limited/

/CORRECTION - Ming Shing Group Holdings Limited/

Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based wet trades and graphene technology company, has entered into a stock purchase agreement to acquire Meals Through Seasons Limited for $510 million payable entirely in company securities. The deal involves issuing 150 million Class A ordinary shares and $360 million in unsecured conve…

LPL Financial Welcomes Conte Wealth Advisors, LLC

LPL Financial Welcomes Conte Wealth Advisors, LLC

LPL Financial announced the integration of Conte Wealth Advisors, LLC, a family-led firm managing approximately $1.6 billion in assets, into its broker-dealer and Registered Investment Advisor platforms. This move aims to support CWA's growth by leveraging LPL's technology, resources, and scale to attract and empower advisors while enhancing the cl…

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

SciSparc Ltd.'s subsidiary NeuroThera Labs, in collaboration with Clearmind Medicine, has advanced their psychedelic drug pipeline with a newly published U.S. patent application covering a novel combination of MDMA and N-acylethanolamines (such as PEA) for the treatment of PTSD, anxiety, and eating disorders. This patent publication coincides with …

Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion

Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion

Callan JMB Inc. has appointed Michael Reger, founder and former CEO of Northern Oil and Gas, as President of its new subsidiary Callan Power LLC, focused on oil and gas resource development, energy resilience, and domestic manufacturing of critical electrical equipment. Leveraging Reger's extensive energy industry and public company leadership expe…

EVA LIVE EXPANDS INTO GLOBAL GAMING MARKET PROJECTED TO EXCEED $200 BILLION THROUGH MAJORITY OWNERSHIP OF INTERNATIONAL GAMING ALLIANCE

EVA LIVE EXPANDS INTO GLOBAL GAMING MARKET PROJECTED TO EXCEED $200 BILLION THROUGH MAJORITY OWNERSHIP OF INTERNATIONAL GAMING ALLIANCE

Eva Live Inc. announces its 60% majority ownership of International Gaming Alliance (IGA), marking its strategic expansion into the global online gaming and lottery market. IGA has signed a three-year Master Services Agreement with Lottery.com International, enabling operations across multiple international territories. Eva Live will leverage its A…

Expion Announces $9.0 Million Initial Closing of Private Placement

Expion Announces $9.0 Million Initial Closing of Private Placement

Expion Energy, Inc. announced the closing of a $9 million initial tranche of a private placement offering involving 8% Convertible Debentures and Warrants, with potential to raise an additional $91 million. The proceeds will be used to acquire oil and gas assets in Eastern Louisiana and for general corporate expenses. The company is broadening its …

La Rosa Holdings Corp. Reports First Half 2026 Results Highlighted by 10% Gross Profit Growth and 42% Improvement in Operating Loss

La Rosa Holdings Corp. Reports First Half 2026 Results Highlighted by 10% Gross Profit Growth and 42% Improvement in Operating Loss

La Rosa Holdings Corp., a US-based real estate and PropTech company, announced first half 2026 financial results marked by a nearly 10% increase in gross profit to $3.7 million and a 42% reduction in operating loss to $4.2 million compared to the prior year. The company also reported a 25% decrease in operating expenses and a 9.4% improvement in ne…

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals has earned its third $10 million milestone payment in 2026 from Novo Nordisk following successful patient dosing in the Phase 1 trial of LX9851, a novel oral small molecule for obesity and metabolic disorders. This achievement brings total milestone payments to $75 million out of a potential $1 billion collaboration deal. Th…